Oppenheimer Increases Imperva (IMPV) Price Target to $60.00

Imperva (NASDAQ:IMPV) had its target price hoisted by research analysts at Oppenheimer from $55.00 to $60.00 in a note issued to investors on Monday. The brokerage presently has an “outperform” rating on the software maker’s stock. Oppenheimer’s price objective indicates a potential upside of 15.72% from the company’s current price.

Other equities analysts have also recently issued reports about the stock. DA Davidson began coverage on shares of Imperva in a research note on Tuesday, April 10th. They set a “buy” rating and a $56.00 target price for the company. Evercore ISI reissued a “buy” rating and issued a $56.00 price objective on shares of Imperva in a research note on Friday, April 27th. Royal Bank of Canada reissued a “buy” rating and issued a $54.00 price objective on shares of Imperva in a research note on Monday, April 23rd. BidaskClub raised shares of Imperva from a “hold” rating to a “buy” rating in a research note on Tuesday, April 17th. Finally, Zacks Investment Research cut shares of Imperva from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 11th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $53.42.

Imperva opened at $51.85 on Monday, according to Marketbeat.com. The firm has a market cap of $1.80 billion, a P/E ratio of -185.18 and a beta of 1.69. Imperva has a fifty-two week low of $37.17 and a fifty-two week high of $53.95.



Imperva (NASDAQ:IMPV) last posted its earnings results on Thursday, April 26th. The software maker reported $0.26 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.19 by $0.07. The company had revenue of $84.24 million during the quarter, compared to analysts’ expectations of $83.77 million. Imperva had a negative net margin of 3.00% and a negative return on equity of 1.63%. Imperva’s quarterly revenue was up 16.5% on a year-over-year basis. During the same period last year, the company posted $0.09 earnings per share. equities analysts predict that Imperva will post -0.61 EPS for the current fiscal year.

Hedge funds have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. boosted its stake in shares of Imperva by 276.2% during the 1st quarter. Russell Investments Group Ltd. now owns 2,588 shares of the software maker’s stock worth $112,000 after purchasing an additional 1,900 shares during the period. Royal Bank of Canada boosted its stake in shares of Imperva by 99.4% during the 1st quarter. Royal Bank of Canada now owns 2,794 shares of the software maker’s stock worth $122,000 after purchasing an additional 1,393 shares during the period. Xact Kapitalforvaltning AB purchased a new position in shares of Imperva during the 1st quarter worth about $205,000. Quadrature Capital Ltd purchased a new position in shares of Imperva during the 4th quarter worth about $224,000. Finally, Sensato Investors LLC purchased a new position in shares of Imperva during the 1st quarter worth about $225,000.

Imperva Company Profile

Imperva, Inc engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments.

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply